John G. Ullman & Associates’s Gilead Sciences GILD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change %
Capital Flow Portfolio Weight Portfolio Position
2025
Q2
$778K Sell
7,019
-2
-0% -$222 0.12% 106
2025
Q1
$787K Buy
7,021
+1,786
+34% +$200K 0.12% 112
2024
Q4
$484K Buy
5,235
+257
+5% +$23.7K 0.07% 129
2024
Q3
$417K Hold
4,978
0.06% 143
2024
Q2
$342K Buy
4,978
+500
+11% +$34.3K 0.05% 151
2024
Q1
$328K Buy
4,478
+700
+19% +$51.3K 0.05% 141
2023
Q4
$306K Sell
3,778
-72
-2% -$5.83K 0.05% 140
2023
Q3
$289K Sell
3,850
-100
-3% -$7.49K 0.05% 148
2023
Q2
$304K Hold
3,950
0.05% 149
2023
Q1
$328K Sell
3,950
-24
-0.6% -$1.99K 0.05% 150
2022
Q4
$341K Buy
3,974
+124
+3% +$10.6K 0.05% 143
2022
Q3
$238K Hold
3,850
0.04% 147
2022
Q2
$238K Buy
3,850
+50
+1% +$3.09K 0.04% 151
2022
Q1
$226K Hold
3,800
0.03% 157
2021
Q4
$276K Buy
+3,800
New +$276K 0.04% 144
2020
Q4
Sell
-3,665
Closed -$232K 157
2020
Q3
$232K Buy
+3,665
New +$232K 0.05% 115
2019
Q4
Sell
-4,780
Closed -$303K 149
2019
Q3
$303K Sell
4,780
-915
-16% -$58K 0.06% 119
2019
Q2
$385K Buy
5,695
+2,495
+78% +$169K 0.07% 109
2019
Q1
$208K Sell
3,200
-200
-6% -$13K 0.04% 124
2018
Q4
$213K Buy
3,400
+200
+6% +$12.5K 0.04% 122
2018
Q3
$247K Buy
+3,200
New +$247K 0.04% 116
2015
Q2
Sell
-2,069
Closed -$203K 147
2015
Q1
$203K Buy
+2,069
New +$203K 0.04% 133
2014
Q4
Sell
-2,119
Closed -$226K 146
2014
Q3
$226K Buy
+2,119
New +$226K 0.04% 136